C21 Investments Inc.

CXXI

CA12675Q1019

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 01:29:31 25/05/2024 am IST			5-day change	1st Jan Change
0.455 ^CAD	0.00%		-6.19%	+42.19%

08/05	C21 Investments Inc. Reports Earnings Results for the Fourth Quarter Ended January 31, 2024	CI
08/05	C21 Investments Inc. Reports Earnings Results for the Full Year Ended January 31, 2024	CI

C21 Investments Inc. Reports Earnings Results for the Full Year Ended January 31, 2024

May 08, 2024 at 10:54 pm IST

C21 Investments Inc. reported earnings results for the full year ended January 31, 2024. For the full year, the company reported sales was USD 28.29 million compared to USD 28.89 million a year ago. Net loss was USD 2.47 million compared to net income of USD 0.293211 million a year ago.

Latest news about C21 Investments Inc.

C21 Investments Inc. Reports Earnings Results for the Fourth Quarter Ended January 31, 2024	08/05	CI
C21 Investments Inc. Reports Earnings Results for the Full Year Ended January 31, 2024	08/05	CI
C21 Investments Inc. announced that it has received CAD 4 million in funding	06/05	CI
C21 Investments Inc. announced that it expects to receive CAD 4 million in funding	15/03	CI
C21 Investments Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	14/12	CI
C21 Investments Swings to Loss in Fiscal Q2; Down 5.7%	21/23/21	MT
C21 Investments Swings to Loss in Fiscal Q2	21/23/21	MT
C21 Investments Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023	21/23/21	CI
C21 Investments Inc. Announces Appointment of Aron Swan as Chief Operating Officer	08/23/08	CI
C21 Investments Swings to Loss in Fiscal Q1, Revenue Rises	29/23/29	MT
C21 Investments Inc. Reports Earnings Results for the First Quarter Ended April 30, 2023	29/23/29	CI
C21 Investments Inc. Reports Earnings Results for the Full Year Ended January 31, 2023	14/23/14	CI
C21 Investments' Fiscal Q4 Loss Widens, Revenue Falls; Completes Full Repayment of $30 Million Senior Secured Note	02/23/02	MT
C21 Investments' Shares Rally After Senior Secured Note Fully Repaid	02/23/02	DJ
C21 Investments' Fiscal Q4 Loss Widens, Revenue Falls; Completes Full Repayment of $30 Million Senior Secured Note	02/23/02	MT
C21 Investments Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2022	15/22/15	CI
C21 Investments Q2 EPS US$0.02 Vs US$0.03 Year Ago; Revenue Falls	22/22/22	MT
C21 Investments Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2022	22/22/22	CI
C21 Investments Inc. Reports Earnings Results for the First Quarter Ended April 30, 2022	16/22/16	CI
An unknown buyer signed a binding agreement to acquire select assets in Oregon of C21 Investments Inc. for $2 million.	19/22/19	CI
C21 Investments Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2021	16/21/16	CI
C21 Investments Inc. Reports Earnings Results for the Second Quarter Ended July 31, 2021	28/21/28	CI
C21 Investments Inc. Reports Earnings Results for the First Quarter Ended April 30, 2021	30/21/30	CI
C21 Investments Inc. Reports Earnings Results for the Full Year Ended January 31, 2021	01/21/01	CI
C21 Investments Inc. Auditor Raises 'Going Concern' Doubt	31/21/31	CI

Chart C21 Investments Inc.

Duration

Period

More charts

Company Profile

C21 Investments Inc. is a Canada-based vertically integrated cannabis company. The Company cultivates, processes, and distributes cannabis and hemp-derived consumer products in the United States. The Company is focused on value creation through the disciplined acquisition and integration of core retail, manufacturing, and distribution assets in strategic markets, leveraging industry- retail revenues with multi-market branded consumer packaged goods. The Company holds licenses in Nevada spanning the entire cannabis supply chain. The Company owns Silver State Relief and Silver State Cultivation in Nevada, including legacy Oregon brands Phantom Farms, Hood Oil and Eco Firma Farms. These brands produce and distribute a broad range of tetrahydrocannabinol (THC) and cannabidiol (CBD) products from cannabis flowers, pre-rolls, cannabis oil, vaporizer cartridges and edibles. The Company operates in the state of Nevada.

Sector

Pharmaceuticals

Calendar

14/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
C21 INVESTMENTS INC.	+42.19%	39.87M
DONG-E-E-JIAO CO.,LTD.	+37.65%	6.11B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-19.68%	4.33B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+4.49%	3.22B
TASLY PHARMACEUTICAL GROUP CO., LTD	-15.69%	2.96B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-5.64%	2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+44.89%	1.92B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-12.71%	1.61B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-4.27%	1.57B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-14.86%	1.51B